Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Atul Kumar Bhan, M.D., M.B.,B.S.

Co-Author

This page shows the publications co-authored by Atul Bhan and Raymond Chung.
Connection Strength

1.397
  1. A Prospective Cohort Study of Novel Markers of Hepatitis B Virus Replication in Human Immunodeficiency Virus Coinfection. Clin Gastroenterol Hepatol. 2021 Dec 29.
    View in: PubMed
    Score: 0.245
  2. Shear-wave elastography for the estimation of liver fibrosis in chronic liver disease: determining accuracy and ideal site for measurement. Radiology. 2015 Mar; 274(3):888-96.
    View in: PubMed
    Score: 0.149
  3. Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection. J Hepatol. 2009 Apr; 50(4):705-11.
    View in: PubMed
    Score: 0.100
  4. The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C. Liver Int. 2009 May; 29(5):748-53.
    View in: PubMed
    Score: 0.100
  5. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer. 2007 Jun 15; 109(12):2490-6.
    View in: PubMed
    Score: 0.089
  6. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med. 2004 Jul 29; 351(5):451-9.
    View in: PubMed
    Score: 0.073
  7. Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C. Clin Transplant. 2004 Apr; 18(2):166-73.
    View in: PubMed
    Score: 0.071
  8. Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation. 2004 Mar 15; 77(5):703-10.
    View in: PubMed
    Score: 0.071
  9. Recurrent allograft HCV presenting as acute cellular rejection: successful management with interferon and ribavirin alone. Clin Transplant. 2003 Jun; 17(3):275-83.
    View in: PubMed
    Score: 0.067
  10. Reply to Li, Henry, and Nguyen. Am J Gastroenterol. 2022 Apr 01; 117(4):688.
    View in: PubMed
    Score: 0.062
  11. Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection. Clin Infect Dis. 2021 Oct 25.
    View in: PubMed
    Score: 0.060
  12. A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America. Hepatology. 2021 09; 74(3):1174-1189.
    View in: PubMed
    Score: 0.060
  13. Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B. Am J Gastroenterol. 2021 08 01; 116(8):1686-1697.
    View in: PubMed
    Score: 0.059
  14. Diagnostic Accuracy of Shear Wave Elastography as a Non-invasive Biomarker of High-Risk Non-alcoholic Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease. Ultrasound Med Biol. 2020 04; 46(4):972-980.
    View in: PubMed
    Score: 0.054
  15. Validation of Shear Wave Elastography Cutoff Values on the Supersonic Aixplorer for Practical Clinical Use in Liver Fibrosis Staging. Ultrasound Med Biol. 2017 06; 43(6):1125-1133.
    View in: PubMed
    Score: 0.044
  16. Amyloidosis of the liver on shear wave elastography: case report and review of literature. Abdom Imaging. 2015 Oct; 40(8):3078-83.
    View in: PubMed
    Score: 0.040
  17. Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection. AIDS. 2006 Feb 14; 20(3):345-51.
    View in: PubMed
    Score: 0.020
  18. Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection. AIDS. 2005 May 20; 19(8):767-73.
    View in: PubMed
    Score: 0.019
  19. Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy. Transplantation. 1998 Nov 15; 66(9):1254-8.
    View in: PubMed
    Score: 0.012
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.